Biochemie und Chemie
Refine
Year of publication
- 2022 (1)
Document Type
- Doctoral Thesis (1)
Language
- English (1)
Has Fulltext
- yes (1)
Is part of the Bibliography
- no (1)
Keywords
- Acute Promyelocytic Leukemia (1)
- Deubiquitination (1)
- Interferon response (1)
- SUMOylation (1)
Institute
Post-translational modifications (PTMs) of cell fate regulating proteins determine their stability, localization and function and control the activation of cell protective signaling pathways. Particularly in aberrantly dividing cancer cells the surveillance of cell cycle progression is essential to control tumorigenicity. In a variety of carcinomas, lymphomas and leukemias, the tumor-suppressive functions of the apoptosis- and senescence-regulating promyelocytic leukemia protein (PML) is controlled by numerous PTMs. PML poly-ubiquitylation and polySUMOylation at several lysine (K) residues induce PML degradation that is correlated to a progressive and invasive cancer phenotype. Besides several known E3 ubiquitin protein ligases that are involved in PML degradation, less is known about PML-specific deubiquitylases (DUBs), the respective DUB-controlled ubiquitin conjugation sites and the functional consequences of PML (de)ubiquitylation. Here, we show that the pro-tumorigenic DUB USP22 critically regulates PML protein stability by modifying PML residue K394 in advanced colon carcinoma cells in vitro and that this modification also impacts the homeostasis and function of the leukemia-associated mutant variant PML-RARα. We found that ablation of USP22 decreases PML mono-ubiquitylation and correlates with a prolonged protein half-live in colon carcinoma and acute promyelocytic leukemia (APL) cell lines. Additionally, silencing of USP22 enhances interferon and interferon-stimulated gene (ISG) expression in APL cells in vitro, which together with prolonged PML-RARα stability increases the APL cell sensitivity towards differentiation treatment. In accordance with the novel roles of USP22 as suppressor of the interferon response in human intestinal epithelial cells (hIECs), our findings imply USP22-dependent surveillance of PML-RARα stability and interferon signaling in human leukemia cells, revealing USP22 as central regulator of leukemia pathogenesis.